Skip to content
Screener

Glaukos GKOS Operating Cash Flow

Operating Cash Flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$8.62B+122%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$813M-29.0%
Sight Sciences, Inc. logo
Sight Sciences, Inc.SGHT
-$5.66M+24.9%
AbbVie logo
AbbVieABBV
$3.83B+134%
Schering-Plough logo
Schering-PloughSGP
-$13.54M-65.2%
Bausch + Lomb logo
Bausch + LombBLCO
$153M+337%

Other financials

Income statement

See full
Revenue$185.6M+49.5%
Gross profit$151.6M+55.9%
Operating income-$17.3M+23.9%
Net income-$18.4M+6.5%
EPS (diluted)-$0.31+8.8%

Balance sheet

See full
Cash & equivalents$114.5M+13.6%
Total debt$105.9M-1.4%
Total equity$682.5M-10.8%
Total assets$920.5M-6.7%

Cash flow

See full
CapEx$2.7M+132%
Free cash flow-$16.5M+19.4%

Valuation

See full
Market cap$10.08B+98.7%
Enterprise value$10.07B+98.2%
P/S16.5×+4.7×

Profitability

See full
Gross margin61%-15.4pp
Operating margin-31.6%+22.2pp
Net margin-30.7%+23.3pp
FCF margin-13.2%-3.9pp

Returns & leverage

See full
Return on equity-26%-11,301pp
Debt / equity0.2×0.0×
Current ratio-0.5×

Where this comes from

Reported directly by Glaukos in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Glaukos’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-324201
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Prepaid expenses and other current assets(7,401)(919)
Accounts payable and accrued liabilities2,195(113)
Other assets(293)(817)
Net cash provided by (used in) operating activities2,297(11,542)
Investing activities
Purchases of short-term investments(66,847)(116,765)
Proceeds from sales and maturities of short-term investments82,62994,411
Purchases of property and equipment(6,697)(3,117)

Item 1. Financial Statements

FAQ

What is Glaukos's operating cash flow?
Glaukos (GKOS) reported operating cash flow of $14.82M in Q2 2026.
What is the long-term trend for Glaukos's operating cash flow?
Over 2 years (2022 to 2024), Glaukos's operating cash flow has grown at a 36.7% compound annual growth rate (CAGR), from -$33.08M to -$61.83M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Glaukos's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude